Drug Type Small molecule drug |
Synonyms Articaine Hydrochloride and Epinephrine Tartrate, Compound Articaine Hydrochloride, 复方盐酸阿替卡因 + [8] |
Action agonists, modulators |
Mechanism ADRA1 agonists(Adrenergic receptor alpha-1 agonists), SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), β-adrenoceptors agonists(Beta adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Germany (01 Jan 1976), |
Regulation- |
Molecular FormulaC13H21ClN2O3S |
InChIKeyGDWDBGSWGNEMGJ-UHFFFAOYSA-N |
CAS Registry23964-57-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | Germany | 01 Jan 1976 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory pain | Preclinical | United States | - | - |